Citations

Clear

1893 citation(s) found for "Wu, Kenneth".

Association of low numbers of CD 206‐positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis
Bernard, C, Gibbons, Simon J. , Mann, Inderjit, Froschauer, Lukas, Harbison, Sean, Snape, William J., McCallum, Richard W. , Sarosiek, Irene , Koch, Kenneth L. , Tonascia, James , Hamilton, Frank A., Kendrick, Michael L. , Shen, K. Robert , Pasricha, Pankaj J. , Farrugia, Gianrico , Parkman, Henry P. , Abell, Thomas L. , Hasler, William L. , Nguyen, Linda Anh B. , Gibbons, S J

Mayo Clinic

Neurogastroenterology & Motility | July 15, 2014 | Volume: 26 | Issue: 9 | Pages: 1275-1284

10.1111/nmo.12389 | PMID 25041465 Get It

Abstract Background There is increasing evidence for specific cellular changes in the stomach of patients with diabetic ( DG ) and idiopathic ( IG ) gastroparesis. The most significant findings are loss of interstitial cells of Cajal ( ICC ), neuronal abnormalities, and an immune cellular infiltrate. Studies done in diabetic mice have shown a cytoprotective effect of CD 206+ M2 macrophages. To quantify overall immune cellular infiltrate, identify macrophage populations, and quantify CD 206+ and i NOS + cells. To investigate associations between cellular phenotypes and ICC . Methods Full thickness gastric body biopsies were obtained from non‐diabetic controls (C), diabetic controls ( DC ), DG , and IG patients. Sections were labeled for CD 45, CD 206, Kit, i NOS , and putative human macrophage markers ( HAM 56, CD 68, and EMR 1). Immunoreactive cells were quantified from the circular muscle layer. Key Results Significantly fewer ICC were detected in DG and IG tissues, but there were no differences in the numbers of cells immunoreactive for other markers between patient groups. There was a significant correlation between the number of CD 206+ cells and ICC in DG and DC patients, but not in C and IG and a significant correlation between i NOS + cells and ICC in the DC group, but not the other groups. CD 68 and HAM 56 reliably labeled the same cell populations, but EMR 1 labeled other cell types. Conclusions & Inferences Depletion of ICC and correlation with changes in CD 206+ cell numbers in DC and DG patients suggests that in humans, like mice, CD 206+ macrophages may play a cytoprotective role in diabetes. These findings may lead to novel therapeutic options, targeting alternatively activated macrophages.
I nternational S ociety of N europathology‐ H aarlem
Louis, David N. , Burger, Peter C. , Ellison, David W. , Reifenberger, Guido , Deimling, Andreas von , Aldape, Kenneth , Collins, V. Peter , Figarella‐Branger, Dominique , Fuller, Gregory N. , Giangaspero, Felice , Hawkins, Cynthia , Kleihues, Paul, Korshunov, Andrey , Lopes, M. Beatriz S. , Ng, Ho‐Keung , Ohgaki, Hiroko, Paulus, Werner , Pietsch, Torsten , Rosenblum, Marc K. , Söylemezoğlu, Figen , Wiestler, Otmar D., Wesseling, Pieter , Perry, Arie , Brat, Daniel J. , Eberhart, Charles G. , Giannini, Caterina , Kros, Johan M. , Rushing, Elisabeth Jane , Wesseling, Pieter , von Deimling, Andreas

Mayo Clinic

Brain Pathology | July 2, 2014 | Volume: 24 | Issue: 5 | Pages: 429-435

10.1111/bpa.12171 | PMID 24990071 Get It

Abstract Major discoveries in the biology of nervous system tumors have raised the question of how non‐histological data such as molecular information can be incorporated into the next W orld H ealth O rganization ( WHO ) classification of central nervous system tumors. To address this question, a meeting of neuropathologists with expertise in molecular diagnosis was held in H aarlem, the N etherlands, under the sponsorship of the I nternational S ociety of N europathology ( ISN ). Prior to the meeting, participants solicited input from clinical colleagues in diverse neuro‐oncological specialties. The present “white paper” catalogs the recommendations of the meeting, at which a consensus was reached that incorporation of molecular information into the next WHO classification should follow a set of provided “ ISN ‐ H aarlem” guidelines. Salient recommendations include that (i) diagnostic entities should be defined as narrowly as possible to optimize interobserver reproducibility, clinicopathological predictions and therapeutic planning; (ii) diagnoses should be “layered” with histologic classification, WHO grade and molecular information listed below an “integrated diagnosis”; (iii) determinations should be made for each tumor entity as to whether molecular information is required, suggested or not needed for its definition; (iv) some pediatric entities should be separated from their adult counterparts; (v) input for guiding decisions regarding tumor classification should be solicited from experts in complementary disciplines of neuro‐oncology; and (iv) entity‐specific molecular testing and reporting formats should be followed in diagnostic reports. It is hoped that these guidelines will facilitate the forthcoming update of the fourth edition of the WHO classification of central nervous system tumors.
Abnormal Movements in Children With Migraine
Youssef, Paul E., Mack, Kenneth J.

Mayo Clinic

Journal of Child Neurology | July 2, 2014 | Volume: 30 | Issue: 3 | Pages: 285-288

10.1177/0883073814538499 | PMID 24985753 Get It

The cause and treatment of functional movement disorders and nonepileptic spells in children is poorly understood, and an association with migraine has not previously been reported. We retrospectively reviewed children diagnosed with chronic or episodic migraine at our institution from 2006 to 2013 to determine the proportion with nonorganic movement disorders, their phenomenology, provoking factors, and natural history. Thirty-two patients were identified, representing 4.3% of patients with chronic migraine and 0.9% of patients with episodic migraine. Twenty-four of the 32 (75%) had chronic migraine, whereas 8 (25%) had episodic migraine. Nonepileptic spells was the most common phenomenon in both cohorts, followed by tremor and functional gait disorders. Severe migraine attacks preceded these movements in the majority of patients. With appropriate migraine therapy, significant reduction or resolution of these movements was reported. We conclude that nonorganic movement disorders are observed in pediatric migraine, are more prevalent among chronic migraineurs, and can resolve with improved pain control.
Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy
Takeuchi, Kenneth K., Crawford, Howard C, Crawford, Howard C.

Mayo Clinic

Gut | June 26, 2014 | Volume: 63 | Issue: 9 | Pages: 1379-1380

10.1136/gutjnl-2014-307317 | PMID 24966285 Get It

A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
Brenner, Darren R. , Scherer, Dominique , Muir, Kenneth , Schildkraut, Joellen M. , Spitz, Margaret R., Goode, Ellen L. , Ulrich, Cornelia M. , Hung, Rayjean J., Hung, Rayjean J. , Boffetta, Paolo , Marchand, Loı̈c Le , Chan, Andrew T. , Hung, Rayjean J., Hung, Rayjean J , Muir, Kenneth

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 25, 2014 | Volume: 23 | Issue: 9 | Pages: 1729-1751

10.1158/1055-9965.epi-14-0064 | PMID 24962838 Get It

Abstract Inflammation is a facilitating process for multiple cancer types. It is believed to affect cancer development and progression through several etiologic pathways, including increased levels of DNA adduct formation, increased angiogenesis, and altered antiapoptotic signaling. This review highlights the application of inflammatory biomarkers in epidemiologic studies and discusses the various cellular mediators of inflammation characterizing the innate immune system response to infection and chronic insult from environmental factors. Included is a review of six classes of inflammation-related biomarkers: cytokines/chemokines, immune-related effectors, acute-phase proteins, reactive oxygen and nitrogen species, prostaglandins and cyclooxygenase-related factors, and mediators such as transcription factors and growth factors. For each of these biomarkers, we provide a brief overview of the etiologic role in the inflammation response and how they have been related to cancer etiology and progression within the literature. We provide a discussion of the common techniques available for quantification of each marker, including strengths, weaknesses, and potential pitfalls. Subsequently, we highlight a few under-studied measures to characterize the inflammatory response and their potential utility in epidemiologic studies of cancer. Finally, we suggest integrative methods for future studies to apply multifaceted approaches to examine the relationship between inflammatory markers and their roles in cancer development. Cancer Epidemiol Biomarkers Prev; 23(9); 1729–51. ©2014 AACR.
Nonspecific motility disorders, irritable esophagus, and chest pain
Krarup, Anne Lund , Drewes, Asbjørn Mohr , Hejazi, Reza , McCallum, Richard W. , Achem, Sami R., Liao, Donghua , Gregersen, Hans N. , Vega, Kenneth J. , Frazzoni, Marzio , Frazzoni, Leonardo , Clarke, John O.

Mayo Clinic

Annals of the New York Academy of Sciences | June 6, 2014 | Volume: 1300 | Issue: 1 | Pages: 96-109

10.1111/nyas.12244 | PMID 24117637 Get It

This paper presents commentaries on whether Starling's law applies to the esophagus; whether erythromycin affects esophageal motility; the relationship between hypertensive lower esophageal sphincter and vigorous achalasia; whether ethnic‐ and gender‐based norms affect diagnosis and treatment of esophageal motor disorders; health care and epidemiology of chest pain; whether normal pH excludes esophageal pain; the role of high‐resolution manometry in noncardiac chest pain; whether pH–impedance should be included in the evaluation of noncardiac chest pain; whether there are there alternative therapeutic options to PPI for treating noncardiac chest pain; and the usefulness of psychological treatment and alternative medicine in noncardiac chest pain.
Causes and treatments of achalasia, and primary disorders of the esophageal body
Félix, V. , DeVault, Kenneth R. , Penagini, Roberto , Elvevi, Alessandra, Swanström, Lee L. , Wassenaar, Eelco B., Crespin, Oscar M. , Pellegrini, Carlos A. , Wong, Roy K.H., DeVault, Kenneth, Penagini, Roberto

Mayo Clinic

Annals of the New York Academy of Sciences | June 6, 2014 | Volume: 1300 | Issue: 1 | Pages: 236-249

10.1111/nyas.12254 | PMID 24117646 Get It

The following on achalasia and disorders of the esophageal body includes commentaries on controversies regarding whether patients with complete lower esophageal sphincter (LES) relaxation can be considered to exhibit early achalasia; the roles of different mucle components of the LES in achalasia; sensory neural pathways impaired in achalasia; indications for peroral endoscopic myotomy and advantages of the technique over laparoscopic and thorascopic myotomy; factors contributing to the success of surgical therapy for achalasia; modifications to the classification of esophageal body primary motility disorders in the advent of high‐resolution manometry (HRM); analysis of the LES in differentiating between achalasia and diffuse esophageal spasm (DES); and appropriate treatment for DES, nutcracker esophagus (NE), and hypertensive LES (HTLES).
Outcomes After Curative Thoracic Radiotherapy in Patients With Coronary Artery Disease and Existing Cardiac Stents
Sio, Terence T., Liang, Jackson J. , Novotny, Paul J. , Prasad, Abhiram , Miller, Robert C. , Chang, Kenneth Tou En , Liang, Jackson , Prasad, Abhiram

Mayo Clinic

American Journal of Clinical Oncology | May 30, 2014 | Volume: 39 | Issue: 6 | Pages: 549-555

10.1097/coc.0000000000000092 | PMID 24879471 Get It

Objectives: To evaluate outcomes among cancer patients with preexisting coronary artery disease and cardiac stenting who subsequently underwent thoracic radiotherapy (RT). Methods: From 1998 to 2012, 147 patients received percutaneous coronary intervention (PCI) and then curative external beam RT (>30 Gy, except for Hodgkin lymphoma patients) involving the heart and the lungs. Heart-specific and lung-specific dosimetric parameters were correlated to overall survival (OS) and cardiac-specific survival by Cox variate methods. Results: The mean interval between PCI and cancer diagnosis was 1.8 years (range, 0.1 to 14.2 y). Hypertension was present in 105 patients (71%), and hyperlipidemia in 82 (56%). At the time of analysis, 69 patients (47%) were alive, 3 (2%) died of cardiac causes, and 53 (36%) died of cancer. In multivariate analyses, OS since PCI was related to cancer type (P=0.004). Decreased OS since cancer diagnosis was related to older age (P<0.001) and increased percentage of targeted volume or organ receiving 20 Gy or more for lung (P<0.001), even after controlling for sex, cancer type, and stage. However, for non–cancer-specific survival and major adverse cardiac event-free survival, older age and underlying cardiopulmonary comorbidities dominated (rather than heart and lung dosimetric parameters) in predicting worse outcome for these patients with preexisting coronary artery disease who later underwent RT. Conclusions: Cancer type, older age, and preexisting cardiopulmonary comorbidities and risk factors most significantly predicted clinical outcome and survival for these patients with existing coronary stents who subsequently received thoracic RT. Dosimetric detrimental effects were not significant in our study.
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Diamond, Eli L. , Dagna, Lorenzo , Hyman, David M. , Cavalli, Giulio , Jankú, Filip , Estrada‐Veras, Juvianee , Ferrarini, Marina , Abdel‐Wahab, Omar , Heaney, Mark , Feeley, Nancy , McClain, Kenneth L. , Vaglio, Augusto , Colby, Thomas V. , Arnaud, Laurent , Haroche, Julien , Colby, Thomas, Scheel, Paul J. , Ferrero, Elisabetta , Diamond, Eli L , Abdel-Wahab, Omar , McClain, Kenneth L , Vaglio, Augusto

Mayo Clinic

Blood | May 22, 2014 | Volume: 124 | Issue: 4 | Pages: 483-492

10.1182/blood-2014-03-561381 | PMID 24850756 Get It

Abstract Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAFV600E mutations in >50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Although ∼500 to 550 cases have been described in the literature to date, increased physician awareness has driven a dramatic increase in ECD diagnoses over the last decade. ECD frequently involves multiple organ systems and has historically lacked effective therapies. Given the protean clinical manifestations and the lack of a consensus-derived approach for the management of ECD, we provide here the first multidisciplinary consensus guidelines for the clinical management of ECD. These recommendations were outlined at the First International Medical Symposium for ECD, comprised of a comprehensive group of international academicians with expertise in the pathophysiology and therapy of ECD. Detailed recommendations on the initial clinical, laboratory, and radiographic assessment of ECD patients are presented in addition to treatment recommendations based on critical appraisal of the literature and clinical experience. These formalized consensus descriptions will hopefully facilitate ongoing and future research efforts in this disorder.
Radiation reduction in pediatric and adult congenital patients during cardiac catheterization
Mauriello, Daniel, Fetterly, Kenneth A. , Lennon, Ryan J. , Reeder, Guy S., Taggart, Nathaniel W. , Hagler, Donald J. , Cetta, Frank , Mauriello, Daniel A, Cabalka, Allison K. , Taggart, Nathaniel W

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 30, 2014 | Volume: 84 | Issue: 5 | Pages: 801-808

10.1002/ccd.25533 | PMID 24782364 Get It

ObjectivesOur objective was to determine if technical changes combined with radiation safety initiatives reduced the radiation dose delivered to patients during congenital catheterization.BackgroundUse of ionizing radiation is necessary during cardiac catheterization. Minimizing radiation dose, while maintaining clinically useful image quality, is an important safety issue. In our congenital heart center intentional practice changes, including technical changes and provider awareness initiatives, were implemented to decrease radiation dose.MethodsData were retrospectively collected for all procedures involving children and adults with congenital heart disease (CHD) undergoing catheterization over 45 months. Cases were divided into three categories including: noninterventional (NI), simple intervention (SI), and complex intervention (CI). The change in dose was modeled as log of cumulative air kerma (Ka,r). The change in Ka,r was evaluated for each procedural category as well as changes occurring as a function of age and weight.ResultsConsidering all procedures (n = 1,082), Ka,r decreased by 61%. In the NI group (n = 481), Ka,r decreased by 71%. In the SI group (n = 424), Ka,r decreased by 74%. The Ka,r for the 10–17 year old group (n = 125) and those ≥18 years (n = 709) decreased 74 and 67%, respectively. The Ka,r decreased 72 and 66% for those 20–60 kg and ≥60 kg, respectively. Groups not showing significant change in Ka,r included CI, age ≤9 years, and weight ≤20 kg.ConclusionsThrough technical changes and provider awareness initiatives, our institution dramatically reduced the radiation dose in the majority of pediatric and adult CHD patients undergoing cardiac catheterization. © 2014 Wiley Periodicals, Inc.